UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany

European urology open science (Online), 2020-11, Vol.21, p.S144

2020

Volltextzugriff (PDF)

PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

Value in health, 2012-11, Vol.15 (7), p.A431-A431

2012

Volltextzugriff (PDF)

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Pharmacokinetics of a 3-month implant

Journal of geriatric oncology, 2012-10, Vol.3, p.S85-S85

2012

Volltextzugriff (PDF)

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 1-month implant

Journal of geriatric oncology, 2012-10, Vol.3, p.S86-S87

2012

Volltextzugriff (PDF)

A new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Clinical experience from a non-interventional study

Journal of geriatric oncology, 2012-10, Vol.3, p.S87-S87

2012

Volltextzugriff (PDF)

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 3-month implant

Journal of geriatric oncology, 2012-10, Vol.3, p.S86-S86

2012

Volltextzugriff (PDF)

Value of intermittent androgen deprivation in the context of the current data situation

Aktuelle Urologie, 2013-07, Vol.44 (4), p.271

2013

Volltextzugriff (PDF)

What Patient Groups Have Special Benefits Using the GNRH-Antagonist Degarelix? Conclusions Based on Real Life Data from a German Registry

Annals of oncology, 2012-09, Vol.23, p.ix306

2012

Volltextzugriff (PDF)

Metastasiertes kastrationsresistentes Prostatakarzinom: Aktuelle Daten, neue Therapieoptionen und strukturiertes Therapiemonitoring

Urologe. Ausgabe A, 2016-09, Vol.55 (9), p.1206-1212

2016

Volltextzugriff (PDF)

Real-Life-Daten zur Behandlung von Knochenmetastasen bei Patientinnen mit Mammakarzinom in Deutschland – Darstellung des Versorgungsalltags

Senologie (Stuttgart), 2015, Vol.12 (2)

2015

Volltextzugriff (PDF)

Metastasiertes kastrationsresistentes Prostatakarzinom: Positionspapier für ein strukturiertes Therapiemonitoring

Urologe. Ausgabe A, 2014-05, Vol.53 (5), p.710-714

2014

Volltextzugriff (PDF)

838 Risk-adapted screening for bladder cancer: Daily routine in preventive care with the assessment tool RiskCheck Bladder Cancer© in the Urological Health-Service Research Association IQUO, Germany

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e838-e838

2015

Volltextzugriff (PDF)

Transport Phenomena in Materials Processing

2016

Volltextzugriff (PDF)

Stellenwert der intermittierenden Androgendeprivation im Kontext der aktuellen Datenlage

Aktuelle Urologie, 2013-07, Vol.44 (4), p.271-276

2013

Volltextzugriff (PDF)

371 Preventive medical care in bladder cancer is possible: Risk-adapted screening in urology performed by IQUO-Germany

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e371-e372

2013

Volltextzugriff (PDF)

Metastatic castration-resistant prostate cancer : Clinical data, new treatment options and therapy monitoring

Urologe. Ausgabe A, 2016-09, Vol.55 (9), p.1206

2016

Volltextzugriff (PDF)

C99 PROVE OF PRINCIPLE BY HEALTH SERVICE RESEARCH OF THE GERMAN INSTITUTION IQUO FOR RISK-ADAPTED SCREENING IN BLADDER CANCER USING THE ONLINE-TOOL RISKCHECK BLADDER CANCER(c) (RCBC)

European urology supplements : official journal of the European Association of Urology, 2012-10, Vol.11 (4), p.105-106

2012

Volltextzugriff (PDF)

Interdisciplinary recommendations concerning the therapy for hormone-refractory prostatic carcinoma

Aktuelle Urologie, 2006-05, Vol.37 (3), p.201-204

2006

Volltextzugriff (PDF)

Studienteilnahme in der urologischen Facharztpraxis

Urologe. Ausgabe A, 2005-12, Vol.44 (12), p.1449-1451

2005

Volltextzugriff (PDF)

Metastatic castration-resistant prostate cancer: position paper for structured therapy monitoring

Urologe. Ausgabe A, 2014-05, Vol.53 (5), p.710

2014

Volltextzugriff (PDF)

991 COMBINATION THERAPY WITH DUTASTERIDE PLUS TAMSULOSIN REDUCES MEDICAL RESOURCE UTILISATION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: 4-YEAR DATA FROM THE COMBAT STUDY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.311-311

2010

Volltextzugriff (PDF)

Interdisziplinäre Therapieempfehlungen zur Behandlung des hormonrefraktären Prostatakarzinoms

Aktuelle Urologie, 2006-05, Vol.37 (3), p.201-204

2006

Volltextzugriff (PDF)

Therapie des hormonresistenten Prostatakarzinoms mit Docetaxel

Onkologie (Heidelberg, Germany), 2006-08, Vol.12 (8), p.798-802

2006

Volltextzugriff (PDF)

Study participation in urological specialty practices

Urologe. Ausgabe A, 2005-12, Vol.44 (12), p.1449-1451

2005

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Physics
(17)
Physical Sciences
(15)
Life Sciences & Biomedicine
(13)
Humans
(10)
Physics, Nuclear
(9)
Physics, Particles & Fields
(9)
Male
(7)
Aufsatzsammlung
(6)
Germany
(6)
Urology
(6)
Biological And Medical Sciences
(5)
Hematology, Oncology And Palliative Medicine
(5)
Internal Medicine
(5)
Technology
(5)
Urology & Nephrology
(5)
Fundamental And Applied Biological Sciences. Psychology
(4)
Instruments & Instrumentation
(4)
Materials
(4)
Nuclear Science & Technology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany

PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Pharmacokinetics of a 3-month implant

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 1-month implant

A new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Clinical experience from a non-interventional study

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 3-month implant

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Value of intermittent androgen deprivation in the context of the current data situation

What Patient Groups Have Special Benefits Using the GNRH-Antagonist Degarelix? Conclusions Based on Real Life Data from a German Registry

Metastasiertes kastrationsresistentes Prostatakarzinom: Aktuelle Daten, neue Therapieoptionen und strukturiertes Therapiemonitoring

Real-Life-Daten zur Behandlung von Knochenmetastasen bei Patientinnen mit Mammakarzinom in Deutschland – Darstellung des Versorgungsalltags

Metastasiertes kastrationsresistentes Prostatakarzinom: Positionspapier für ein strukturiertes Therapiemonitoring

838 Risk-adapted screening for bladder cancer: Daily routine in preventive care with the assessment tool RiskCheck Bladder Cancer© in the Urological Health-Service Research Association IQUO, Germany

Transport Phenomena in Materials Processing

Stellenwert der intermittierenden Androgendeprivation im Kontext der aktuellen Datenlage

371 Preventive medical care in bladder cancer is possible: Risk-adapted screening in urology performed by IQUO-Germany

Metastatic castration-resistant prostate cancer : Clinical data, new treatment options and therapy monitoring

C99 PROVE OF PRINCIPLE BY HEALTH SERVICE RESEARCH OF THE GERMAN INSTITUTION IQUO FOR RISK-ADAPTED SCREENING IN BLADDER CANCER USING THE ONLINE-TOOL RISKCHECK BLADDER CANCER(c) (RCBC)

Interdisciplinary recommendations concerning the therapy for hormone-refractory prostatic carcinoma

Studienteilnahme in der urologischen Facharztpraxis

Metastatic castration-resistant prostate cancer: position paper for structured therapy monitoring

991 COMBINATION THERAPY WITH DUTASTERIDE PLUS TAMSULOSIN REDUCES MEDICAL RESOURCE UTILISATION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: 4-YEAR DATA FROM THE COMBAT STUDY

Interdisziplinäre Therapieempfehlungen zur Behandlung des hormonrefraktären Prostatakarzinoms

Therapie des hormonresistenten Prostatakarzinoms mit Docetaxel

Study participation in urological specialty practices

Suchergebnisse filtern